Analysts Offer Insights on Technology Companies: Verint Systems (VRNT), Xero Limited (OtherXROLF) and 8X8 (EGHT)
There's a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Verint Systems (VRNT – Research Report), Xero Limited (XROLF – Research Report) and 8X8 (EGHT – Research Report) with bullish sentiments.
Confident Investing Starts Here:
Verint Systems (VRNT)
In a report issued on May 18, Dan Bergstrom from RBC Capital maintained a Buy rating on Verint Systems, with a price target of $29.00. The company's shares closed last Monday at $17.93, close to its 52-week low of $17.64.
According to TipRanks.com, Bergstrom is a 4-star analyst with an average return of 12.0% and a 60.0% success rate. Bergstrom covers the Technology sector, focusing on stocks such as CSG Systems International, CommVault Systems, and Fortinet.
Currently, the analyst consensus on Verint Systems is a Strong Buy with an average price target of $29.00.
Xero Limited (XROLF)
RBC Capital analyst Garry Sherriff maintained a Buy rating on Xero Limited on May 15 and set a price target of A$210.00. The company's shares closed last Thursday at $111.75.
Sherriff has an average return of 20.0% when recommending Xero Limited.
According to TipRanks.com, Sherriff is ranked #1346 out of 9558 analysts.
Xero Limited has an analyst consensus of Strong Buy, with a price target consensus of $128.40, implying a 14.9% upside from current levels. In a report issued on May 15, Morgans also upgraded the stock to Buy with a A$215.00 price target.
8X8 (EGHT)
Bank of America Securities analyst Michael Funk reiterated a Buy rating on 8X8 yesterday and set a price target of $3.00. The company's shares closed last Monday at $1.80, close to its 52-week low of $1.51.
According to TipRanks.com, Funk is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -8.0% and a 42.9% success rate. Funk covers the Technology sector, focusing on stocks such as CCC Intelligent Solutions Holdings, Zoom Video Communications, and Weave Communications.
The word on The Street in general, suggests a Hold analyst consensus rating for 8X8 with a $2.22 average price target, which is a 26.1% upside from current levels. In a report issued on May 14, B.Riley Financial also maintained a Buy rating on the stock with a $3.00 price target.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Analysts' Opinions Are Mixed on These Healthcare Stocks: Quince Therapeutics (QNCX) and Moderna (MRNA)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Quince Therapeutics (QNCX – Research Report) and Moderna (MRNA – Research Report). Confident Investing Starts Here: Quince Therapeutics (QNCX) In a report issued on June 4, Jason McCarthy from Maxim Group maintained a Buy rating on Quince Therapeutics, with a price target of $6.00. The company's shares closed last Friday at $1.17. According to McCarthy 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -19.2% and a 28.3% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as Reviva Pharmaceuticals Holdings, Brainstorm Cell Therapeutics, and SELLAS Life Sciences Group. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Quince Therapeutics with a $6.67 average price target. Moderna (MRNA) In a report released today, Matt Phipps from William Blair reiterated a Hold rating on Moderna. The company's shares closed last Friday at $27.46. According to Phipps is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -8.1% and a 41.7% success rate. Phipps covers the Healthcare sector, focusing on stocks such as NewAmsterdam Pharma Company, Ultragenyx Pharmaceutical, and Janux Therapeutics Inc. Currently, the analyst consensus on Moderna is a Hold with an average price target of $49.29, an 88.1% upside from current levels. In a report issued on May 27, Barclays also maintained a Hold rating on the stock with a $40.00 price target.
Business Insider
16 hours ago
- Business Insider
Analysts Offer Insights on Consumer Cyclical Companies: Five Below (FIVE) and Autoliv (ALV)
Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Five Below (FIVE – Research Report) and Autoliv (ALV – Research Report). Confident Investing Starts Here: Five Below (FIVE) Barclays analyst Seth Sigman maintained a Hold rating on Five Below on June 5 and set a price target of $120.00. The company's shares closed last Friday at $127.35. According to Sigman 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -7.0% and a 53.9% success rate. Sigman covers the NA sector, focusing on stocks such as Driven Brands Holdings, Floor & Decor Holdings, and Advance Auto Parts. Five Below has an analyst consensus of Moderate Buy, with a price target consensus of $118.63, which is a -7.0% downside from current levels. In a report issued on May 28, Citi also maintained a Hold rating on the stock with a $121.00 price target. Autoliv (ALV) Kepler Capital analyst Alexandre Raverdy maintained a Buy rating on Autoliv on June 5 and set a price target of $100.00. The company's shares closed last Friday at $105.62. According to Raverdy is ranked #5408 out of 9607 analysts. Autoliv has an analyst consensus of Strong Buy, with a price target consensus of $111.31, a 4.8% upside from current levels. In a report issued on May 28, UBS also maintained a Buy rating on the stock with a $123.00 price target.
Yahoo
2 days ago
- Yahoo
Verint Systems Jumps 20% on Q1 AI-Driven Beat
Verint Systems (NASDAQ:VRNT) surges 20% premarket after reporting Q1 fiscal 2026 revenue of $208.1 million, down 6% year-over-year but topping consensus by $13.88 million, and non-GAAP diluted EPS of $0.29, which beat estimates by $0.06. Warning! GuruFocus has detected 3 Warning Sign with VRNT. Annual recurring revenue (ARR) growth accelerated to 6% YoY as customers increasingly adopt Verint's AI-powered customer experience suite, underscoring a shift from legacy offerings to cloud-based services. These results highlight sustained AI momentum even as broader software spending faces headwinds. CEO Dan Bodner said Verint's hybrid cloud model accelerates AI deployment, allowing enterprises to rapidly implement new automation and analytics capabilities across customer interactions. We kicked off the year strong, expect our AI momentum to continue and are targeting exiting the year with 8% ARR growth and double-digit free cash flow growth, Bodner said. CFO Grant Highlander added that the revenue upside primarily reflected the timing of two large, unbundled SaaS deals and affirmed that full-year guidance remains unchanged despite the deal timing lift. With peers like NICE (NICE) and Genesys (GENESYS) also investing heavily in AI, Verint's Q1 performance stands out for sustaining both growth and operating margin discipline. Investors should care because the earnings beat and accelerating ARR growth demonstrate Verint's ability to leverage AI to drive sustainable revenue, insulating it against broader macro pressures. As ARR climbs and cost control sharpens operating margins, Verint appears well-positioned to gain market share as enterprises modernize contact center and customer engagement operations in an increasingly digital-first landscape. This article first appeared on GuruFocus.
